Buying guide

Evie Ring (and EvieMED) vs RingConn (Gen 2 / Gen 3) in 2026

Comparing 2 humanoid robots across availability, pricing, capabilities, and verified deployments. Current as of 2026.

Key differences

On DEPLOY's record, RingConn (Gen 2 / Gen 3) has more verified real-world deployments (2 versus 1) than Evie Ring (and EvieMED) as of 2026; DEPLOY counts a deployment only when confirmed at a named site with a primary source.

RingConn (Gen 2 / Gen 3) has more verified real-world deployments (2 vs 1).

Attribute	No image on file Evie Ring (and EvieMED)View full model page →	No image on file RingConn (Gen 2 / Gen 3)View full model page →
Manufacturer	Movano Health	RingConn
Form factor	biometric	biometric
Maturity	commercial	commercial
Autonomy	—	◐ not independently verified
Availability	pausedpaused	shipping-nowshipping
Price	Not announced	$199-$299 (actual sale price)
Capability claims	—	Tracks sleep (claimed-only, claimed) Tracks heart health (claimed-only, claimed) Tracks fitness and activity (claimed-only, claimed)
Brain	—	—
Verified deployments	1Movano Health	2RingConn, RingConn
Privacy practices	—	8third-party-sharing, data-sale, biometric-storage, cloud-upload, location-tracking, data-deletion-control, data-retention, training-data-use
Sources on file	8	12

Track this matchup

Get told the moment Evie Ring (and EvieMED) or RingConn (Gen 2 / Gen 3) changes. Verified changes only, the second they are real. No press-release noise.

Evie Ring (and EvieMED)

RingConn (Gen 2 / Gen 3)

Editorial summaries

Evie Ring (and EvieMED)

Movano Health's Evie Ring is a women's-health-focused smart ring (menstrual-cycle tracking, sleep, energy, heart rate, SpO2, and mood and goal trends; general-wellness, not a diagnostic) and the lifecycle-state-paused archetype of DEPLOY's biometric ring sub-cohort. The verified-vs-claimed distinction is critical: Evie Ring sales are PAUSED, not discontinued.

Following Movano Health's Corvex reverse merger (closed March 19, 2026), an AI-infrastructure pivot, and a 1-for-10 reverse split, the company paused Evie Ring sales while a divestiture of its EvieMED clinical line is pending. EvieMED (the B2B/clinical variant) is an FDA 510(k)-cleared pulse oximeter and heart-rate device (December 2, 2024) for clinical trials, remote patient monitoring, and payors and pharma.

DEPLOY records the consumer Evie Ring at paused availability with no current retail price. Aggregators routinely flatten this as 'Movano discontinued the Evie Ring'; the accurate state is sales-paused amid a corporate pivot, with the EvieMED divestiture pending (an intention where not yet closed). Movano Health trades as NASDAQ: MOVE (CEO John Mastrototaro).

RingConn (Gen 2 / Gen 3)

RingConn (the Gen 2 at about $279, plus the Gen 2 Air and a Gen 3 arriving late May 2026; from RingConn, Shenzhen) is the subscription-free archetype of the biometric ring sub-cohort: all standard features are free for life, the core positioning against Oura's required membership and Whoop's subscription-only model. Its sensors (PPG, skin temperature, SpO2, accelerometer) drive sleep, heart rate and HRV, and a deep-learning sleep-apnea / AHI screening feature, with 10-to-12-day battery (the charging case extends to about 150 days).

The verified-vs-claimed throughline: the sleep-apnea / AHI feature is a company-claimed screening capability (RingConn cites about 90.7% accuracy) that is NOT FDA-cleared. RingConn's own materials say it is 'actively pursuing clearance' and 'not intended to diagnose'; DEPLOY records the AHI claim as claimed, not cleared, the direct counterpoint to the genuinely-cleared Happy Ring in the same form factor.

On the patent front, RingConn settled and licensed cleanly in the smart-ring ITC litigation; it was not import-banned, unlike Ultrahuman. Price is $279, subscription-free.

Common questions

How do Evie Ring (and EvieMED) and RingConn (Gen 2 / Gen 3) differ?

What is the difference between Evie Ring (and EvieMED) and RingConn (Gen 2 / Gen 3)?

Evie Ring (and EvieMED) and RingConn (Gen 2 / Gen 3) are both biometric robots on the DEPLOY registry. They differ in maker, maturity, price, verified deployments, and how much of their autonomy is independently verified. See the table above for the full head-to-head; each figure is sourced.

Is Evie Ring (and EvieMED) or RingConn (Gen 2 / Gen 3) more autonomous?

On the DEPLOY registry, neither Evie Ring (and EvieMED) nor RingConn (Gen 2 / Gen 3) has capabilities independently verified as fully autonomous yet; their recorded capabilities are teleoperated-assisted, demonstrated, or vendor-claimed. See the table for each capability's verification status.

Which has more verified deployments, Evie Ring (and EvieMED) or RingConn (Gen 2 / Gen 3)?

RingConn (Gen 2 / Gen 3) has more verified deployments (2) on the DEPLOY registry than Evie Ring (and EvieMED) (1). DEPLOY counts a deployment only when confirmed at a named site with a primary source.

Recent coverage

Movano Health secures FDA clearance for EvieMED RingEvie Ring (and EvieMED) · Ben Smith, Deploy Editor · 2026-06-15
FDA exempts more wearable AI features from oversightEvie Ring (and EvieMED) · Ben Smith, Deploy Editor · 2026-04-15

Related comparisons

Keep researching

Keep reading

AI wearable prices: every verified figureAnswer The verified list.All biometric wearablesRegistry Every verified record in the category.Evie Ring (and EvieMED)Model The full model page.RingConn (Gen 2 / Gen 3)Model The full model page.Movano HealthRecord The maker's verified record.RingConnRecord The maker's verified record.

Ask the registry

For AI assistants

Use DEPLOY in Claude, Cursor, and other AI assistants

Connect any MCP-aware assistant to the live registry. Ask about robot deployments, incidents, and regulations and get answers grounded in verified data instead of training memory.

Install instructions Download for Claude Desktop

Machine-readable: this page as markdown.

← Back to all consumer robots